ANGIODYNAMICS INC (ANGO)

Latest Insider Confidence Score

2025Q4

51.6
Bullish

Company insider confidence (by quarter)

2010Q3 2025Q4

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Clemmer James C CEO 882,529 Oct 9, 2025
Avista Capital Partners GP, LLC 10% Owner 381,406 Apr 14, 2017
Avista Capital Partners, L.P. 10% Owner 381,406 Apr 14, 2017
Avista Capital Partners (Offshore), L.P. 10% Owner 381,406 Apr 14, 2017
Navilyst Medical Co-Invest, LLC 10% Owner 381,406 Apr 14, 2017

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Oct 21, 2025 Oct 22, 2025 Weiss Lawrence T SVP, Chief Legal Officer Buy 95.0 +10,000 11.96% ✗ $118.1K
Oct 13, 2025 Oct 14, 2025 Trowbridge Stephen A CFO Buy 60.0 +890 0.35% ✗ $9.9K
Oct 9, 2025 Oct 9, 2025 Clemmer James C CEO Buy 82.5 +10,000 1.15% ✗ $111.5K
Jul 19, 2025 Jul 22, 2025 Trowbridge Stephen A CFO Sell 46.3 -3,969 -1.53% ✗ $34.7K
Jul 19, 2025 Jul 22, 2025 Piccinini Laura SVP International Sell 46.3 -2,599 -3.75% ✗ $22.6K
Jul 19, 2025 Jul 22, 2025 Nighan Warren JR SVP Quality and Regulatory Sell 46.3 -1,263 -1.77% ✗ $11.1K
Jul 19, 2025 Jul 22, 2025 Clemmer James C CEO Sell 42.5 -15,306 -1.72% ✗ $134.1K
Jul 19, 2025 Jul 22, 2025 Campbell Chad Thomas SVP/GM, Vascular Access Sell 46.3 -1,779 -1.89% ✗ $15.6K
Jul 17, 2025 Jul 21, 2025 Piccinini Laura SVP International Sell 46.3 -3,074 -4.24% ✗ $26.9K
Jul 16, 2025 Jul 18, 2025 Nighan Warren JR SVP Quality and Regulatory Neutral 90.0 +29,349 70.18% ✗ -
Jul 16, 2025 Jul 18, 2025 Clemmer James C CEO Neutral 90.0 +206,253 30.26% ✗ -
Jul 16, 2025 Jul 18, 2025 Weiss Lawrence T SVP, Chief Legal Officer Neutral 90.0 +30,900 58.64% ✗ -
Jul 16, 2025 Jul 18, 2025 Trowbridge Stephen A CFO Neutral 90.0 +86,997 50.37% ✗ -
Jul 16, 2025 Jul 18, 2025 Campbell Chad Thomas SVP/GM, Vascular Access Neutral 90.0 +26,268 38.74% ✗ -
Jul 16, 2025 Jul 18, 2025 DONNELLY HOWARD W Director Neutral 90.0 +17,675 11.83% ✗ -
Jul 16, 2025 Jul 18, 2025 Piccinini Laura SVP International Neutral 90.0 +32,423 81.05% ✗ -
Jul 16, 2025 Jul 18, 2025 Burgess Lorinda Director Neutral 90.0 +17,675 47.03% ✗ -
Jul 16, 2025 Jul 18, 2025 Auen Eileen O'Shea Director Neutral 90.0 +17,675 20.31% ✗ -
Jul 16, 2025 Jul 18, 2025 Tarnoff Michael E Director Neutral 90.0 +17,675 26.90% ✗ -
Jul 16, 2025 Jul 18, 2025 REED JAN STERN Director Neutral 90.0 +17,675 20.23% ✗ -
Jul 16, 2025 Jul 18, 2025 Licitra Karen A Director Neutral 90.0 +17,675 24.29% ✗ -
Jul 16, 2025 Jul 18, 2025 JOHNSON WESLEY Director Neutral 90.0 +17,675 14.04% ✗ -
Jan 16, 2025 Jan 17, 2025 Nighan Warren JR SVP Quality and Regulatory Sell 26.3 -4,060 -8.85% ✗ $50K
Dec 2, 2024 Dec 4, 2024 Weiss Lawrence T SVP, Chief Legal Officer Neutral 90.0 +52,697 100.00% ✗ -
Dec 4, 2024 Weiss Lawrence T SVP, Chief Legal Officer Neutral 52.5 - 0.00% ✗ -
Oct 7, 2024 Oct 10, 2024 Nighan Warren JR SVP Quality and Regulatory Buy 77.5 +868 1.93% ✗ $5.3K
Oct 8, 2024 Oct 8, 2024 Trowbridge Stephen A CFO Buy 67.5 +1,700 0.99% ✗ $10K
Oct 7, 2024 Oct 8, 2024 Clemmer James C CEO Buy 87.5 +20,000 3.02% ✗ $120.6K
Jul 17, 2024 Aug 2, 2024 Piccinini Laura SVP International Sell 46.3 -2,485 -5.85% ✗ $18.4K
Jul 17, 2024 Aug 2, 2024 Clemmer James C CEO Sell 42.5 -28,730 -4.16% ✗ $212.6K
Jul 17, 2024 Aug 2, 2024 Nighan Warren JR SVP Quality and Regulatory Sell 46.3 -1,666 -3.57% ✗ $12.3K
Jul 17, 2024 Aug 2, 2024 Campbell Chad Thomas SVP/GM, Vascular Access Sell 46.3 -2,379 -3.39% ✗ $17.6K
Jul 17, 2024 Aug 2, 2024 Trowbridge Stephen A CFO Sell 46.3 -6,601 -3.72% ✗ $48.3K
Jul 20, 2024 Jul 25, 2024 Campbell Chad Thomas SVP/GM, Vascular Access Sell 47.5 -754 -1.17% ✗ $5.4K
Jul 20, 2024 Jul 25, 2024 Piccinini Laura SVP International Sell 47.5 -1,029 -2.63% ✗ $7.3K
Jul 20, 2024 Jul 25, 2024 Clemmer James C CEO Sell 48.8 -6,354 -0.99% ✗ $45.3K
Jul 20, 2024 Jul 25, 2024 Nighan Warren JR SVP Quality and Regulatory Sell 47.5 -528 -1.27% ✗ $3.8K
Jul 20, 2024 Jul 25, 2024 Trowbridge Stephen A CFO Sell 50.0 -1,384 -0.82% ✗ $9.9K
Jul 19, 2024 Jul 23, 2024 Clemmer James C CEO Neutral 67.5 +3,817 0.60% ✗ -
Jul 19, 2024 Jul 23, 2024 Piccinini Laura SVP International Sell 46.3 -1,983 -4.83% ✗ $14.2K
Jul 19, 2024 Jul 23, 2024 Nighan Warren JR SVP Quality and Regulatory Sell 47.5 -735 -1.74% ✗ $5.3K
Jul 19, 2024 Jul 23, 2024 Clemmer James C CEO Sell 42.5 -8,307 -1.29% ✗ $59.6K
Jul 19, 2024 Jul 23, 2024 Campbell Chad Thomas SVP/GM, Vascular Access Sell 47.5 -1,025 -1.57% ✗ $7.4K
Jul 17, 2024 Jul 19, 2024 Piccinini Laura SVP International Neutral 90.0 +21,971 115.07% ✗ -
Jul 17, 2024 Jul 19, 2024 Nighan Warren JR SVP Quality and Regulatory Neutral 90.0 +18,733 79.62% ✗ -
Jul 17, 2024 Jul 19, 2024 Campbell Chad Thomas SVP/GM, Vascular Access Neutral 90.0 +12,350 23.29% ✗ -
Jul 17, 2024 Jul 19, 2024 REED JAN STERN Director Neutral 90.0 +20,541 30.74% ✗ -
Jul 17, 2024 Jul 19, 2024 JOHNSON WESLEY Director Neutral 90.0 +20,541 19.50% ✗ -
Jul 17, 2024 Jul 19, 2024 Tarnoff Michael E Director Neutral 90.0 +20,541 45.48% ✗ -
Jul 17, 2024 Jul 19, 2024 Clemmer James C CEO Neutral 90.0 +105,811 19.63% ✗ -
Jul 17, 2024 Jul 19, 2024 DONNELLY HOWARD W Director Neutral 90.0 +20,541 15.94% ✗ -
Jul 17, 2024 Jul 19, 2024 Burgess Lorinda Director Neutral 90.0 +20,541 120.54% ✗ -
Jul 17, 2024 Jul 19, 2024 Trowbridge Stephen A CFO Neutral 90.0 +38,953 30.22% ✗ -
Jul 17, 2024 Jul 19, 2024 Licitra Karen A Director Neutral 90.0 +20,541 39.34% ✗ -
Jul 17, 2024 Jul 19, 2024 Auen Eileen O'Shea Director Neutral 90.0 +20,541 30.89% ✗ -
Apr 8, 2024 Apr 8, 2024 Clemmer James C CEO Buy 82.5 +10,000 1.89% ✗ $67K
Feb 29, 2024 Mar 4, 2024 Trowbridge Stephen A CFO Neutral 77.5 +1,927 1.52% ✗ -
Jul 19, 2023 Sep 21, 2023 Trowbridge Stephen A CFO Sell 42.5 -6,975 -5.21% ✗ $62.2K
Jul 19, 2023 Sep 21, 2023 Helsel Dave SVP Global Operations and R&D Sell 46.3 -3,477 -9.16% ✗ $31K
Jul 19, 2023 Sep 21, 2023 Centea Scott SVP/GM, VIT Sell 46.3 -2,716 -4.14% ✗ $24.2K
Jul 19, 2023 Sep 21, 2023 Campbell Chad Thomas SVP/GM, Vascular Access Sell 46.3 -3,103 -5.53% ✗ $27.7K
Jul 19, 2023 Sep 21, 2023 Clemmer James C CEO Sell 40.0 -34,296 -5.73% ✗ $305.9K
Jul 19, 2023 Jul 26, 2023 Clemmer James C CEO Sell 42.5 -11,379 -2.03% ✗ $101.5K
Jul 19, 2023 Jul 26, 2023 Helsel Dave SVP Global Operations and R&D Sell 46.3 -1,575 -4.82% ✗ $14K
Jul 19, 2023 Jul 26, 2023 Campbell Chad Thomas SVP/GM, Vascular Access Sell 46.3 -1,404 -2.73% ✗ $12.5K
Jul 19, 2023 Jul 26, 2023 Centea Scott SVP/GM, VIT Sell 46.3 -1,230 -2.00% ✗ $11K
Jul 19, 2023 Jul 26, 2023 Trowbridge Stephen A CFO Sell 46.3 -3,159 -2.56% ✗ $28.2K
Jul 20, 2023 Jul 25, 2023 Trowbridge Stephen A CFO Sell 46.3 -1,384 -1.19% ✗ $12K
Jul 20, 2023 Jul 25, 2023 Clemmer James C CEO Sell 42.5 -6,354 -1.19% ✗ $55.2K
Jul 20, 2023 Jul 25, 2023 Helsel Dave SVP Global Operations and R&D Sell 47.5 -697 -2.40% ✗ $6.1K
Jul 20, 2023 Jul 25, 2023 Centea Scott SVP/GM, VIT Sell 47.5 -588 -1.00% ✗ $5.1K
Jul 20, 2023 Jul 25, 2023 Piccinini Laura SVP International Sell 47.5 -1,029 -5.11% ✗ $9K
Jul 20, 2023 Jul 25, 2023 Campbell Chad Thomas SVP/GM, Vascular Access Sell 47.5 -754 -1.56% ✗ $6.6K
Jul 19, 2023 Jul 21, 2023 Piccinini Laura SVP International Neutral 90.0 +14,168 237.96% ✗ -
Jul 19, 2023 Jul 21, 2023 Trowbridge Stephen A CFO Neutral 90.0 +28,691 32.87% ✗ -
Jul 19, 2023 Jul 21, 2023 Helsel Dave SVP Global Operations and R&D Neutral 90.0 +10,789 59.29% ✗ -
Jul 19, 2023 Jul 21, 2023 Centea Scott SVP/GM, VIT Neutral 90.0 +10,588 22.00% ✗ -
Jul 19, 2023 Jul 21, 2023 Meteny Dennis S Director Neutral 90.0 +17,041 13.86% ✗ -
Jul 19, 2023 Jul 21, 2023 Clemmer James C CEO Neutral 90.0 +92,181 20.80% ✗ -
Jul 19, 2023 Jul 21, 2023 JOHNSON WESLEY Director Neutral 90.0 +17,041 19.30% ✗ -
Jul 19, 2023 Jul 21, 2023 Campbell Chad Thomas SVP/GM, Vascular Access Neutral 90.0 +11,384 30.87% ✗ -
Jul 19, 2023 Jul 21, 2023 DONNELLY HOWARD W Director Neutral 90.0 +17,041 15.24% ✗ -
Jul 19, 2023 Jul 21, 2023 REED JAN STERN Director Neutral 90.0 +17,041 34.23% ✗ -
Jul 19, 2023 Jul 21, 2023 Auen Eileen O'Shea Director Neutral 90.0 +17,041 34.45% ✗ -
Jul 19, 2023 Jul 21, 2023 Tarnoff Michael E Director Neutral 90.0 +17,041 60.60% ✗ -
Jul 19, 2023 Jul 21, 2023 Licitra Karen A Director Neutral 90.0 +17,041 48.44% ✗ -
Jul 19, 2023 Jul 21, 2023 Burgess Lorinda Director Neutral 90.0 +17,041 100.00% ✗ -
Jul 21, 2023 Burgess Lorinda Director Neutral 52.5 - 0.00% ✗ -
Jul 14, 2023 Jul 18, 2023 Trowbridge Stephen A CFO Sell 46.3 -1,738 -1.95% ✗ $16.7K
Jul 14, 2023 Jul 18, 2023 Clemmer James C CEO Sell 42.5 -7,168 -1.59% ✗ $68.9K
Jul 14, 2023 Jul 18, 2023 Campbell Chad Thomas SVP/GM, Vascular Access Sell 47.5 -875 -2.32% ✗ $8.4K
Jul 14, 2023 Jul 18, 2023 Centea Scott SVP/GM, VIT Sell 47.5 -868 -1.77% ✗ $8.3K
Jul 14, 2023 Jul 18, 2023 Helsel Dave SVP Global Operations and R&D Sell 47.5 -992 -5.17% ✗ $9.5K
Jun 1, 2023 Jun 2, 2023 Piccinini Laura SVP International Sell 46.3 -1,400 -19.04% ✗ $13.5K
Feb 3, 2023 Feb 7, 2023 Trowbridge Stephen A CFO Sell 50.0 -555 -0.62% ✗ $7.5K
Feb 1, 2023 Feb 7, 2023 ROSENZWEIG RICHARD C SVP and General Counsel Sell 46.3 -1,137 -6.74% ✗ $15.2K
Jan 31, 2023 Feb 1, 2023 Helsel Dave SVP Global Operations and R&D Sell 22.5 -4,633 -19.45% ✗ $60K
Oct 12, 2022 Oct 12, 2022 Trowbridge Stephen A CFO Buy 78.8 +1,083 1.22% ✗ $15K
Oct 10, 2022 Oct 11, 2022 Clemmer James C CEO Buy 82.5 +10,000 2.27% ✗ $150K
Jul 29, 2022 Aug 1, 2022 Helsel Dave SVP Global Operations and R&D Sell 22.5 -5,000 -17.35% ✗ $112.2K